FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/05/086221 [Registered on: 02/05/2025] Trial Registered Prospectively
Last Modified On: 01/05/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Medical Device 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparing Two Airway Devices for Safer Anesthesia in Keyhole Gallbladder Surgery. 
Scientific Title of Study   Comparison of clinical performance of LMA BlockBuster and Ambu AuraGain Supraglottic Airways in Laparoscopic Cholecystectomy: A Randomised Controlled Trial  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Aspari Mahammad Azeez 
Designation  Assistant Professor 
Affiliation  All India Institute of Medical Sciences,Guwahati 
Address  2052, Department of Anaesthesiology, Critical Care and Pain Medicine,2nd floor, OPD building, AIIMS Guwahati, Silbharal, Changsari, Kamrup, Assam.

Kamrup
ASSAM
781101
India 
Phone  8427693477  
Fax    
Email  aspariazeez@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Aspari Mahammad Azeez 
Designation  Assistant Professor 
Affiliation  All India Institute of Medical Sciences,Guwahati 
Address  2052, Department of Anaesthesiology, Critical Care and Pain Medicine,2nd floor, OPD building, AIIMS Guwahati, Silbharal, Changsari, Kamrup, Assam.

Kamrup
ASSAM
781101
India 
Phone  8427693477  
Fax    
Email  aspariazeez@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Aspari Mahammad Azeez 
Designation  Assistant Professor 
Affiliation  All India Institute of Medical Sciences,Guwahati 
Address  2052, Department of Anaesthesiology, Critical Care and Pain Medicine,2nd floor, OPD building, AIIMS Guwahati, Silbharal, Changsari, Kamrup, Assam.

Kamrup
ASSAM
781101
India 
Phone  8427693477  
Fax    
Email  aspariazeez@gmail.com  
 
Source of Monetary or Material Support  
Department of Anaesthesiology, Critical Care and Pain Medicine,2nd floor, OPD building, AIIMS Guwahati, Silbharal, Changsari, Kamrup, Assam.Pin code 781101 
 
Primary Sponsor  
Name  AIIMS Guwahati 
Address  All India Institute of medical Sciences Guwahati Silbharal Changsari, Guwahati, Assam 781101 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Aspari Mahammad Azeez  AIIMS Guwahati  Operation theatre complex,2nd floor, IPD building, Department of Anaesthesiology, Critical Care and Pain Medicine, AIIMS, Guwahati.781101.
Kamrup
ASSAM 
8427693477

aspariazeez@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee,AIIMS Guwahati  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K802||Calculus of gallbladder without cholecystitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Ambu AuraGain (Group A)  Ambu AuraGain Supraglottic airway insertion after anaesthesia induction 
Comparator Agent  Blockbuster (Group B)  Blockbuster Supra Glottic Airway (SGA) insertion after anaesthesia induction 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1.ASA physical status I-II
2. Scheduled for elective laparoscopic cholecystectomy
 
 
ExclusionCriteria 
Details  1. BMI more than 35 kg/m²
2. Severe gastroesophageal reflux disease
3. Pregnancy
4. History of upper respiratory tract pathology/surgeries
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Oropharyngeal leak pressure.  N1-0,5,15 MIN
N2-0,5,15,30,45,60,75,90 MIN 
 
Secondary Outcome  
Outcome  TimePoints 
Insertion success rate on the first attempt  At SGA insertion time 
Insertion time  at SGA insertion 
Device insertion attempts  at SGA Insertion 
Fiberoptic grade of laryngeal alignment  at SGA Insertion time 
Hemodynamic changes: HR and MAP   at baseline , immediately after SGA insertion 
Ventilation parameters (Peak airway pressure, leak fraction)  at 1 min After SGA insertion (T1),5 min Before Carboperitoneum (T2),5 min After Carboperitoneum (T3),5 min Before Removal of Carboperitoneum (T4),5 min After Removal of Carboperitoneum (T5) 
Incidence of postoperative complications
1. Post-operative sore throat (POST)
2. Hoarseness,
3.Cough
4.Laryngospasm,
5.Blood in SGA on removal
 
first 24 of post operative period 
 
Target Sample Size   Total Sample Size="82"
Sample Size from India="82" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/06/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="11"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This randomized controlled trial compares the clinical performance of LMA BlockBuster® and Ambu® AuraGain™ in patients undergoing laparoscopic cholecystectomy. The primary outcome is oropharyngeal leak pressure (OLP), with secondary outcomes including insertion success, time, fiber-optic view, and postoperative complications. The hypothesis is that BlockBuster® provides a better laryngeal seal and alignment. 160 patients were randomized under standardized general anesthesia.

 
Close